出典: meddic



WordNet   license wordnet

「a microscopic particle of triglycerides produced in the intestines during digestion; in the bloodstream they release their fatty acids into the blood」

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/11/17 13:13:38」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.
  • Kohan AB1.
  • Current opinion in endocrinology, diabetes, and obesity.Curr Opin Endocrinol Diabetes Obes.2015 Apr;22(2):119-25. doi: 10.1097/MED.0000000000000136.
  • PURPOSE OF REVIEW: The purpose of this article is to summarize the recent epidemiological, basic science, and pharmaceutical research linking apolipoprotein C-III (apoC-III) with the development and treatment of cardiovascular disease (CVD).RECENT FINDINGS: ApoC-III is an important emerging target l
  • PMID 25692924
  • Can Genetic Variability in α-Tocopherol Bioavailability Explain the Heterogeneous Response to α-Tocopherol Supplements?
  • Borel P1, Desmarchelier C, Nowicki M, Bott R, Tourniaire F.
  • Antioxidants & redox signaling.Antioxid Redox Signal.2015 Mar 10;22(8):669-78. doi: 10.1089/ars.2014.6144. Epub 2014 Nov 12.
  • Both vitamin E (VE) consumption and blood VE status have been negatively associated with the incidence of degenerative diseases and some cancers. However, the response to VE supplementation is very variable among individuals. This could be due to interindividual variability in VE bioavailability, du
  • PMID 25289663
  • Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function.
  • Deng X1, Walker RG1, Morris J1, Davidson WS1, Thompson TB2.
  • The Journal of biological chemistry.J Biol Chem.2015 Mar 2. pii: jbc.M115.637058. [Epub ahead of print]
  • Apolipoprotein (apo)A-IV2 is a lipid emulsifying protein linked to a range of protective roles in obesity, diabetes and cardiovascular disease. It exists in several states in plasma including lipid-bound in high density lipoproteins (HDL) and chylomicrons and as monomeric and dimeric lipid-free/poor
  • PMID 25733664


  • 血漿交換療法 (特集 高トリグリセライド血症 : 高トリグリセライド血症の最新知見) -- (高トリグリセライド血症の治療)
  • 小池 美菜子,新田 孝作
  • 日本臨床 71(9), 1667-1669, 2013-09
  • NAID 40019789211
  • 高トリグリセライド血症にかかわる遺伝子変異 (特集 高トリグリセライド血症 : 高トリグリセライド血症の最新知見)
  • 高トリグリセライド血症の疾患概念とその臨床的意義 (特集 高トリグリセライド血症 : 高トリグリセライド血症の最新知見)


a large plasma lipoprotein particle, occurring as a droplet consisting primarily of triglycerides and functioning in the transport of neutral lipids from the ... chylomicron chy·lo·mi·cron (kī'lō-mī'krŏn') n. One of the microscopic particles of ...
chylomicron [ki″lo-mi´kron] a particle of the class of lipoproteins responsible for the transport of exogenous cholesterol and triglycerides from the small intestine to tissues after meals. Chylomicrons are spherical particles with a core of ...


Chylomicrons enter the lymphatic Schematic image showing a chylomicronChylomicronschylomicrons – Beyond the Dishchylomicron as a representative Chylomicron. Causes, symptoms, treatment





  • 食事性の脂質を輸送する血漿リポ蛋白質。
  • 大量のトリアシルグリセロールを含み(重量組成で85%)、比較的大きな(75~1000nm)球形リポ蛋白質粒子である。